Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4762911
Max Phase: Preclinical
Molecular Formula: C24H30ClN5O2
Molecular Weight: 455.99
Molecule Type: Unknown
Associated Items:
ID: ALA4762911
Max Phase: Preclinical
Molecular Formula: C24H30ClN5O2
Molecular Weight: 455.99
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)CCCN1CCN(CC(=O)Nc2ccc(-c3nc4cc(Cl)ccc4o3)cc2)CC1
Standard InChI: InChI=1S/C24H30ClN5O2/c1-28(2)10-3-11-29-12-14-30(15-13-29)17-23(31)26-20-7-4-18(5-8-20)24-27-21-16-19(25)6-9-22(21)32-24/h4-9,16H,3,10-15,17H2,1-2H3,(H,26,31)
Standard InChI Key: QCZSJSGSRLHLGG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 455.99 | Molecular Weight (Monoisotopic): 455.2088 | AlogP: 3.66 | #Rotatable Bonds: 8 |
Polar Surface Area: 64.85 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.97 | CX Basic pKa: 9.40 | CX LogP: 3.00 | CX LogD: 0.99 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.56 | Np Likeness Score: -2.06 |
1. Osmaniye D,Korkut Çelikateş B,Sağlık BN,Levent S,Acar Çevik U,Kaya Çavuşoğlu B,Ilgın S,Özkay Y,Kaplancıklı ZA. (2021) Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities., 210 [PMID:33183865] [10.1016/j.ejmech.2020.112979] |
Source(1):